144 related articles for article (PubMed ID: 9306005)
1. Effect of glicentin, oxyntomodulin and related peptides on isolated gastric smooth muscle cells.
Rodier G; Magous R; Mochizuki T; Martinez J; Nguyen DL; Bali JP; Bataille D; Jarrousse C
Pflugers Arch; 1997 Nov; 434(6):729-34. PubMed ID: 9306005
[TBL] [Abstract][Full Text] [Related]
2. Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes.
Rodier G; Magous R; Mochizuki T; Le Nguyen D; Martinez J; Bali JP; Bataille D; Jarrousse C
Endocrinology; 1999 Jan; 140(1):22-8. PubMed ID: 9886802
[TBL] [Abstract][Full Text] [Related]
3. Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine.
Pellissier S; Sasaki K; Le-Nguyen D; Bataille D; Jarrousse C
Neurogastroenterol Motil; 2004 Aug; 16(4):455-63. PubMed ID: 15306001
[TBL] [Abstract][Full Text] [Related]
4. Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats.
Anini Y; Jarrousse C; Chariot J; Nagain C; Yanaihara N; Sasaki K; Bernad N; Le Nguyen D; Bataille D; Rozé C
Pancreas; 2000 May; 20(4):348-60. PubMed ID: 10824688
[TBL] [Abstract][Full Text] [Related]
5. A target cell to oxyntomodulin and glicentin: the antral smooth muscle cell.
Rodier G; Magous R; Mochizuki T; Bali JP; Bataille D; Jarrousse C
Ann N Y Acad Sci; 1998 Dec; 865():458-62. PubMed ID: 9928049
[No Abstract] [Full Text] [Related]
6. Oxyntomodulin reduces hydromineral transport through rat small intestine.
Beauclair F; Eto B; Pansu D; Rodier G; Mochizuki T; Martinez J; Bataille D; Jarrousse C
Dig Dis Sci; 1998 Aug; 43(8):1814-23. PubMed ID: 9724174
[TBL] [Abstract][Full Text] [Related]
7. Development of an oxyntomodulin/glicentin C-terminal radioimmunoassay using a "thiol-maleoyl" coupling method for preparing the immunogen.
Blache P; Kervran A; Martinez J; Bataille D
Anal Biochem; 1988 Aug; 173(1):151-9. PubMed ID: 3189794
[TBL] [Abstract][Full Text] [Related]
8. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure.
Baggio LL; Huang Q; Brown TJ; Drucker DJ
Gastroenterology; 2004 Aug; 127(2):546-58. PubMed ID: 15300587
[TBL] [Abstract][Full Text] [Related]
9. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
Kervran A; Blache P; Bataille D
Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
[TBL] [Abstract][Full Text] [Related]
10. Contraction induced by glicentin on smooth muscle cells from the human colon is abolished by exendin (9-39).
Ayachi SE; Borie F; Magous R; Sasaki K; le Nguyen D; Bali JP; Millat B; Jarrousse C
Neurogastroenterol Motil; 2005 Apr; 17(2):302-9. PubMed ID: 15787950
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line.
Gros L; Thorens B; Bataille D; Kervran A
Endocrinology; 1993 Aug; 133(2):631-8. PubMed ID: 8102095
[TBL] [Abstract][Full Text] [Related]
12. Oxyntomodulin and glicentin: brain-gut peptides in the rat.
Blache P; Kervran A; Bataille D
Endocrinology; 1988 Dec; 123(6):2782-7. PubMed ID: 3197645
[TBL] [Abstract][Full Text] [Related]
13. Oxyntomodulin (glucagon-37) and its C-terminal octapeptide inhibit gastric acid secretion.
Jarrousse C; Audousset-Puech MP; Dubrasquet M; Niel H; Martinez J; Bataille D
FEBS Lett; 1985 Aug; 188(1):81-4. PubMed ID: 4018272
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of gastric acid secretion by oxyntomodulin and its 19-37 fragment in the conscious rat.
Jarrousse C; Carles-Bonnet C; Niel H; Sabatier R; Audousset-Puech MP; Blache P; Kervran A; Martinez J; Bataille D
Am J Physiol; 1993 May; 264(5 Pt 1):G816-23. PubMed ID: 8498507
[TBL] [Abstract][Full Text] [Related]
15. The biological significance of "enteroglucagon." Present status.
Bataille D; Jarrousse C; Kervran A; Depigny C; Dubrasquet M
Peptides; 1986; 7 Suppl 1():37-42. PubMed ID: 3529053
[TBL] [Abstract][Full Text] [Related]
16. Peripheral oxyntomodulin reduces food intake and body weight gain in rats.
Dakin CL; Small CJ; Batterham RL; Neary NM; Cohen MA; Patterson M; Ghatei MA; Bloom SR
Endocrinology; 2004 Jun; 145(6):2687-95. PubMed ID: 15001546
[TBL] [Abstract][Full Text] [Related]
17. Characterization of binding sites for oxyntomodulin on a somatostatin-secreting cell line (RIN T3).
Gros L; Demirpence E; Jarrousse C; Kervran A; Bataille D
Endocrinology; 1992 Mar; 130(3):1263-70. PubMed ID: 1371446
[TBL] [Abstract][Full Text] [Related]
18. Enteroglucagon.
Holst JJ
Annu Rev Physiol; 1997; 59():257-71. PubMed ID: 9074764
[TBL] [Abstract][Full Text] [Related]
19. Central pre-proglucagon derived peptides: opportunities for treatment of obesity.
Larsen PJ; Vrang N; Tang-Christensen M
Curr Pharm Des; 2003; 9(17):1373-82. PubMed ID: 12769729
[TBL] [Abstract][Full Text] [Related]
20. The gastric acid secretagogue gastrin-releasing peptide and the inhibitor oxyntomodulin do not exert their effect directly on the parietal cell in the rat.
Gehl J; Jeppesen JL; Poulsen SS; Holst JJ
Digestion; 1988; 40(3):144-51. PubMed ID: 3234620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
